Status:
COMPLETED
Counterfactual Strategies, Physical Activity, and Wearable Trackers
Lead Sponsor:
Texas A&M University
Collaborating Sponsors:
U.S. National Science Foundation
Conditions:
Financial Stress
Socioeconomic Status
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Physical activity (PA) has been suggested to lower one's risk of developing cancer, type 2 diabetes, and cardiovascular disease. While there are benefits from engaging in PA, many people do not engage...
Detailed Description
A.1 Significance A.1.1 Physical Activity. The CDC suggests that 150-300 minutes of moderate-intensity physical activity (PA) is important to staving off non-communicable diseases (NCD) such as cancer,...
Eligibility Criteria
Inclusion
- 18 years old or older
- access to the internet
- has a smartphone capable of syncing with a Fitbit Inspire 2 via Bluetooth
- and must report low SES by indicating a response of 7 or higher on the Subjective SES Ladder
Exclusion
- Having any physical or cognitive impairment that would impact one's ability to engage in low to moderate levels of exercise
- Must not currently be participating or plan to participate in similar studies or programs.
Key Trial Info
Start Date :
March 30 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 19 2022
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT05192226
Start Date
March 30 2022
End Date
December 19 2022
Last Update
April 12 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Texas A&M University
College Station, Texas, United States, 77843